Sequana Medical NV
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sequana Medical NV
Amylyx is funding research at the Sunnybrook Research Institute to investigate Bax and Bak inhibition in neurodegenerative disease. Repertoire looks into HPV+ cancer with Memorial Sloan Kettering.
Private Company Edition: In other $100m-plus venture capital rounds, Third Harmonic Bio emerged with $155m, including a new $105m series B round. Also, Europe- and Japan-focused Newton Biocapital launched its second VC fund with €50m in initial capital and a €150m fundraising goal.
$47.5m partnership between the foundation and Broad researchers will mine genetic data for insights into disease mechanisms. MD Anderson, Nuvectis each unveil multiple new tie-ups.
LSP says its new fund for medical device and drug development companies will be the biggest fund dedicated to life sciences companies in Europe.
- Medical Devices